Jump to content
Powered by BIOPRO BW
  • BIOPRO BW
  • Healthcare industry
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
Healthcare industry Logo

Main navigation

  • Start page Start page
  • Healthcare industry BW

    Healthcare industry BW

    Close Close
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles

    Articles

    Close Close
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events

    Events

    Close Close
  • Databases

    Databases

    Close Close
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services

    BIOPRO services

    Close Close
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • de
  • en
Show menu Show menu

You are here:

  1. Home
  2. Search
Show:Results per page
  • 25Show results
  • 50Show results
  • 75Show results

Search Results

  • Press release - 04/08/2025

    FOXP1 syndrome: Potential therapeutic approach discovered for rare language development disorder

    FOXP1 syndrome is a congenital disorder in which the brain development of affected children is severely impaired due to a genetic variant. A research team from the Medical Faculty Heidelberg at Heidelberg University has now demonstrated in mice, that the inhibition of a specific enzyme in the brain can improve abnormal behavior and immune cell dysfunction in the brain. The results have been published in the journal Advanced Science.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/foxp1-syndrome-potential-therapeutic-approach-discovered-rare-language-development-disorder
  • Press release - 01/08/2025

    Early Pancreatic Cancer Detection

    Tumors of the pancreas seldom cause symptoms in their early stages. This means that in many cases, they are not diagnosed until late, when the chances of successful treatment are poor. A new non-invasive diagnostic method designed by Fraunhofer researchers is set to make it possible to detect this aggressive form of cancer early on with high accuracy, significantly improving the prognosis for treatment.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/early-pancreatic-cancer-detection
  • Press release - 01/08/2025

    A Less Debilitating Approach to Cancer Diagnosis

    Less radiation exposure during diagnosis and treatment for breast and lung cancer: New Fraunhofer method combines X-ray imaging and radar. In the MultiMed project, which explores multimodal medical imaging in 3D, researchers are developing a method that combines X-ray imaging and radar. It´s not only expected to improve the accuracy and efficacy of diagnosing, monitoring and treating breast and lung cancer but also lighten the burden on patients.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/less-debilitating-approach-cancer-diagnosis
  • Breath test replaces invasive diagnostics - 30/07/2025 Der Sensor auf einer Handfläche, der gerade einmal ein Drittel der des Handtellers bedeckt.

    Novel smartphone sensor offers innovative breath test to detect Helicobacter infection

    The stomach bacterium Helicobacter pylori is widespread and, if left undetected, can impact our well-being and also lead to serious health conditions. While effective treatments exist, a reliable diagnosis is essential. To address this, researchers have developed an affordable breath test that uses a mini-sensor to detect the presence of the bacterium. They are currently working on a smartphone-compatible version for self-testing.

    https://www.gesundheitsindustrie-bw.de/en/article/news/novel-smartphone-sensor-offers-innovative-breath-test-detect-helicobacter-infection
  • Press release - 29/07/2025

    New method to design custom protein binder

    Designing protein binders from scratch has long been a daunting challenge within the field of computational biology. Researchers have now developed an innovative, training-free pipeline that uses the fundamental principle of shape complementarity to design site-specific protein binders, which are then optimised to fit precisely onto chosen target sites. The researchers tested this on proteins linked to cancer.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/new-method-design-custom-protein-binder
  • Press release - 24/07/2025

    The origin of evil: stem cell-like cells are the reason for relapses of blood cancer in children and adolescents

    Stem cell-like leukemia cells are responsible for relapses in children and adolescents with a certain type of blood cancer, T-ALL. Researchers at the Hopp Children's Cancer Center Heidelberg (KiTZ), the Molecular Medicine Partnership Unit and the German Cancer Research Center were able to show this in a study. The results could help to overcome resistance in this form of blood cancer and prevent relapses.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/origin-evil-stem-cell-cells-are-reason-relapses-blood-cancer-children-and-adolescents
  • Press release - 24/07/2025

    What makes cells migrate – and what can stop them

    Konstanz researchers identify an enzyme that plays a role in the migration of cells in our body - not only during normal tissue formation and wound healing, but also when tumor cells metastasize. This makes the enzyme an interesting candidate for potential future therapeutic approaches.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/what-makes-cells-migrate-and-what-can-stop-them
  • Press release - 22/07/2025

    Colorectal cancer in type 2 diabetes: An insightful look into the microenvironment of tumors

    Diabetics have a higher risk of colorectal cancer and often a poorer prognosis after developing the disease. The biological mechanisms behind this association were largely unknown. A research team at the German Cancer Research Center (DKFZ) has now discovered that tumors with a low number of immune cells appear to be particularly susceptible to the harmful effects of diabetes.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/colorectal-cancer-type-2-diabetes-insightful-look-microenvironment-tumors
  • Press release - 18/07/2025

    Faster sepsis diagnosis through hyperspectral imaging and AI

    Sepsis is one of the most dangerous medical emergencies. The condition is the result of a misdirected immune response to an infection, which can quickly lead to organ failure and death. Every hour counts – but early detection is difficult. A new study from Heidelberg now presents an innovative approach: artificial intelligence (AI) and hyperspectral imaging of the skin enable immediate and non-invasive sepsis diagnosis directly at the bedside.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/faster-sepsis-diagnosis-through-hyperspectral-imaging-and-ai
  • AI-supported image recognition accelerates identification of zebrafish mutants - 16/07/2025 Nine zebrafish embryos are shown in which various signalling pathways are disrupted. The zebrafish embryos are marked in different colours with frames - white for ‘normal’, in which the embryo lies around the yolk. Red for ‘dead’, green for 'BMP', and purple for ‘nodal’. Five of the embryos contain a dye.

    EmbryoNet AI automatically identifies developmental disorders

    In complex organisms, embryonic development is tightly regulated by intricate signalling pathways. When these pathways are disrupted, they can lead to characteristic developmental defects that are not easy to detect with the naked eye. Developmental biologist Prof. Dr. Patrick Müller from the University of Konstanz has developed EmbryoNet, an AI-powered software tool that uses image analysis to reliably identify such developmental disorders.

    https://www.gesundheitsindustrie-bw.de/en/article/news/embryonet-ai-automatically-identifies-developmental-disorders
  • Press release - 08/07/2025

    Five million euros for research into early cancer detection

    Investing in a healthier future: The HORNBACH Group is supporting the new National Cancer Prevention Center in Heidelberg with a donation of five million euros. In the future, a new laboratory will conduct research into more effective early detection and screening methods.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/five-million-euros-research-early-cancer-detection
  • Press release - 03/07/2025

    Focus on Muscle Metabolism: Sex Differences in Sport and Obesity

    The skeletal muscles of men and women process glucose and fats in different ways. A study provides the first comprehensive molecular analysis of these differences. The results possibly give an explanation why metabolic diseases such as diabetes manifest differently in women and men – and why they respond differently to physical activity.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/focus-muscle-metabolism-sex-differences-sport-and-obesity
  • Press release - 27/06/2025

    Felix Glang receives Otto Hahn Medal

    Felix Glang, of the Max Planck Institute for Biological Cybernetics in Tübingen, has been awarded the Otto Hahn Medal in recognition of his achievements in developing new magnetic resonance imaging (MRI) methods. Glang's methods enable clearer and faster brain scans.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/felix-glang-receives-otto-hahn-medal
  • Press release - 18/06/2025

    Hector Foundation Prize 2025 for Annika Reinke: “Metrics Reloaded” improves the quality of AI-supported image analysis

    Computer scientist Annika Reinke from the German Cancer Research Center (DKFZ) has been awarded the Hector Foundation Prize 2025, endowed with €10,000, for her outstanding work in the field of AI-supported medical image analysis. She received the award for the project Metrics Reloaded, which can significantly improve the quality and reliability of AI-supported image analysis.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hector-foundation-prize-2025-annika-reinke-metrics-reloaded-improves-quality-ai-supported-image-analysis
  • Diagnostic tool for people with Crohn's disease and ulcerative colitis - 17/06/2025 Graphic showing an app on a mobile phone that displays ‘Hey Hanna’ and below it the days of the week and information such as ‘Current relapse forecast: high risk of relapse’ and a ‘Your check-in’ function. On the left you can see a section entitled ‘Sleep quality’ with a curve, below which is a question ‘How high was your HRV?’. On the top right you can see a section with a question ‘What IBD symptoms are you currently experiencing’

    Chronic inflammatory bowel disease - using an app to sustainably improve everyday life

    Keeping appointments? Planning everyday life? For people living with chronic inflammatory bowel disease (IBD), sudden and unpredictable flare-ups can severely limit their ability to participate in daily life. The start-up coreway aims to improve the quality of life for individuals affected by IBD by leveraging data-driven insights and contributing to the advancement of personalised medicine.

    https://www.gesundheitsindustrie-bw.de/en/article/news/chronic-inflammatory-bowel-disease-using-app-sustainably-improve-everyday-life
  • Press release - 16/06/2025

    Novel laboratory models pave the way for targeted therapies for childhood sarcomas

    Sarcomas in soft tissue usually occur in young people and are difficult to treat. Due to a lack of laboratory models, the causes of their development are poorly understood. A team of researchers has now succeeded in creating mouse models with a functioning immune system that replicate sarcoma types that remain unstudied. The method opens up new avenues for the targeted development of immunotherapies for children and adolescents with sarcomas.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/novel-laboratory-models-pave-way-targeted-therapies-childhood-sarcomas
  • Press release - 11/06/2025

    Antiviral tests on protective clothing for infection control

    Textiles functionalized with antiviral agents are intended to reduce the risk of transmission of pathogens, particularly in a medical environment. These antiviral properties must be carefully tested and verified in laboratory tests. The biological testing laboratory of the German Institutes of Textile and Fiber Research Denkendorf has examined antiviral activities with coronaviruses as part of a research project on textiles for infection control.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/antiviral-tests-protective-clothing-infection-control
  • Press release - 05/06/2025

    Colorectal cancer screening via smartphone?

    Colorectal cancer screening programs are currently underutilized in Germany. This also applies to testing for blood in the stool. The immunological stool tests can detect tiny amounts of blood in the stool. Scientists at the German Cancer Research Center (DKFZ) have investigated whether smartphone-based testing could be a meaningful alternative or supplement to traditional laboratory tests.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/colorectal-cancer-screening-smartphone
  • Press release - 26/05/2025

    Explainable artificial intelligence increases the accuracy and endurance of dermatologists in melanoma diagnosis

    Scientists at the German Cancer Research Center (DKFZ) have shown in an international eye-tracking study that dermatologists not only improve their diagnostic accuracy by using explainable artificial intelligence, but also show significantly less fatigue when assessing challenging cases. The researchers were able to demonstrate this by measuring a reduction in cognitive stress indicators.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/explainable-artificial-intelligence-increases-accuracy-and-endurance-dermatologists-melanoma-diagnosis
  • Press release - 22/05/2025

    Six Clusters of Excellence for the University of Tübingen

    Tübingen achieves remarkable success and has good chance of maintaining its University of Excellence title – Top research in three areas to be sustained from other sources of support.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/six-clusters-excellence-university-tubingen
  • Press release - 12/05/2025

    NMI expertise for new VDI guideline on bioprinting - now available

    VDI Guideline 5708 “Bioprinting, methods and definitions”: What sounds technical and sober at first glance is an important step forward in the future field of 3D bioprinting. The guideline was developed under Dr. Hanna Hartmann from the NMI in Reutlingen and Prof. Dr. Jürgen Groll from the University Hospital of Würzburg. It creates a binding, practical basis for reproducible and quality-assured bioprinting procedures.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/nmi-expertise-new-vdi-guideline-bioprinting-now-available
  • Press release - 08/05/2025

    Childhood brain tumors develop early in highly specialized nerve cells

    Medulloblastomas, childhood brain tumors in children, are thought to develop between the first trimester of pregnancy and the end of the first year of life. Researchers have now published their findings in the journal Nature. They analyzed the genetic changes of each individual cancer cell in tumor samples in order to reconstruct which genetic changes occur first during tumor development and when.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/childhood-brain-tumors-develop-early-highly-specialized-nerve-cells
  • Press release - 07/05/2025

    Contactless. Precise. Pioneering: Muscle Monitoring with Quantum Sensors

    A research team led by PD Dr. Justus Marquet and from the Hertie Institute for Clinical Brain Research has developed two methods that allow muscle activity and training-induced adaptations to be measured completely contactlessly. The studies demonstrate that magnetic fields generated during muscle activity can be captured using highly sensitive quantum sensors - without the need for electrodes or skin contact.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/contactless-precise-pioneering-muscle-monitoring-quantum-sensors
  • Press release - 16/04/2025

    Hereditary Alzheimer’s: Blood Marker for Defective Neuronal Connections Rises Early

    Individuals with a genetic predisposition to Alzheimer’s disease show altered blood levels indicating damaged neuronal contacts as early as 11 years before the expected onset of dementia symptoms. This is evident in the levels of the protein “beta-synuclein”. An international team report these findings in the journal “Alzheimer’s & Dementia”. The biomarker studied here could potentially help to detect neurodegeneration at an early stage.

    https://www.gesundheitsindustrie-bw.de/en/article/press-release/hereditary-alzheimers-blood-marker-defective-neuronal-connections-rises-early
  • Baden-Württemberg AI Alliance - 08/04/2025 There are two large computer screens on a desk with a computer mouse and keyboard. The screens show a stylized human head and a head in which parts of the brain structure are stylized. They are surrounded by a network.

    Achieving widespread use of AI

    Artificial intelligence presents both opportunities and risks. The Baden-Württemberg AI Alliance is dedicated to fostering collaboration among AI stakeholders to ensure that AI solutions deliver tangible benefits to citizens and businesses across the state. The alliance will also place greater emphasis on advancing AI applications within the healthcare sector.

    https://www.gesundheitsindustrie-bw.de/en/article/news/achieving-widespread-use-ai

Page 1 / 8

sb_search.block.search_result.other.pages

  • 1
  • 2
  • 3
  • 4
  • 5
  • …
  • 8
  • eine Seite zurück
  • Extend search to all portals
  • Search the Healthcare industry database
  • Search the Research institutions
Search terms
Portal
Information type
  • Type
    Event date
    From
    To
  • Type
  • Publication date
    Topics
    Topics
  • Publication date
Reset

Footer navigation

  • Healthcare industry BW
    • At a glance
    • The biotechnology sector
    • Medical technology
    • The pharmaceutical industry
    • Training & university education
    • Company foundation
    • Infrastructure
    • Clusters & Networks
  • Articles
    • Latest news
    • Selected press releases
    • Dossiers
    • Red biotechnology
    • Medical technology
    • Pharmaceutics
    • Diagnostics
    • Basic research
    • Selected publications
  • Events
  • Databases
    • Funding
    • Healthcare industry database
    • Research institutions
  • BIOPRO services
    • BIOPRO services and offers
    • Contacts
    • Information channels
  • Project pages
    • MDR & IVDR
    • Innovation & Startups
  • Portals
    • BIOPRO BW
    • Healthcare industry
  • To top

stay informed

Newsletter abonnieren

Social Media

  • Xing Xing
  • Twitter visit Twitter
  • LinkedIn visit LinkedIn
  • Rss visit RSS
  • Privacy statement
  • Accessability Declaration
  • Legal notice
  • Sitemap
  • Contact
© 2025
Website address: https://www.gesundheitsindustrie-bw.de/en/search